News

Melanoma has a reputation for quickly developing resistance to chemotherapy, but the reason for this has remained unclear.

University of Queensland Diamantina Institute researchers Dr Roberta Mazzieri and Davide Moi have contributed to an important new gene therapy study published in Nature this week.

A vaccine to treat non-Hodgkin’s lymphoma is one step closer after a University of Queensland Diamantina Institute researcher received a grant from the Leukaemia Foundation of Queensland.

The development of novel immune therapies and vaccines in Brisbane and Perth has been awarded an $11.8 million program grant from the National Health and Medical Research Council.

Genotyping is again in the news after the US Food and Drug Administration ordered US genomics company 23andMe to cease conducting genetic testing.

Dr Roberta Mazzieri at the University of Queensland Diamantina Institute is working with cancer researchers in Italy to develop a non-toxic treatment for human breast cancer that delivers an anti-cancer molecule directly to a tumour.

University of Queensland Diamantina Institute researcher Dr Liliana Endo Munoz has discovered that the cells responsible for normal bone destruction may help prevent bone cancer from spreading.

An international study that has identified new genetic regions involved in rheumatoid arthritis has shed light on existing medicines that could be effective in treating the disease.

A strategic partnership between The University of Queensland and global pharmaceutical company LEO Pharma will investigate the genetic causes of squamous cell carcinoma, the world’s second most common skin cancer.

Professor David Evans has been awarded an esteemed Australian Research Council Future Fellowship for his work on the genetic basis of Ankylosing Spondylitis.

Scientists from The University of Queensland’s Diamantina Institute (UQDI) and Institute for Molecular Bioscience (IMB) have identified three new genes behind Jeune Syndrome.

A number of University of Queensland Diamantina Institute researchers have been announced as recipients of National Health and Medical Research Council (NHMRC) grants.

Scientists at The University of Queensland's Diamantina Institute (UQDI) and Monash University have made a breakthrough in understanding the high-risk genes behind people’s development of rheumatoid arthritis.

A University of Queensland researcher is combining genetics and statistics to shed new light on conditions such as coronary heart disease, asthma and diabetes.

The University of Queensland's scientific excellence will be on show at the AusBiotech Conference in Brisbane in October.

A unique partnership between medical and research visionaries was realised when the Governor-General, Her Excellency the Honourable Quentin Bryce AC CVO, officially opened the new Translational Research Institute in Brisbane.

University of Queensland researchers have contributed to the development of a new approach to detecting coeliac disease, revealing the immune disorder is far more common than previously recognised.

A new rheumatoid arthritis treatment has moved a step closer to reality with the announcement of collaboration between a University of Queensland start-up company and a major pharmaceutical firm.